What is Zykadia (Ceritinib)
Zykadia is a cancer medication that interferes with the growth and spread of cancer cells in the body. Zykadia is used to treat non-small cell lung cancer caused by a defect in a certain gene.
Drug Manufacturer / Marketeer :
- Zykadia is indicated for the treatment of patients with anaplastic lymphoma kinase (ALK) positive metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib
- This indication is approved under accelerated approval based on tumor response rate and duration of response. An improvement in survival or disease related symptoms has not been established.
For treatment related information, please consult your treating Physician.
Zykadia 150 mg is a hard gelatin capsule with opaque blue cap and opaque white body containing a white to off-white powder.
Supplied in a bottle of 70 capsules
Storage and handling:
Store at 20°- 25° C, excursions permitted to 15° to 30° C.
How do we source the Drug?
SMIQ Pharma-India will assist in sourcing the drug through its efficient network, across the globe, and ensure the delivery is prompt. However, a valid prescription from the treating Oncologist is mandatory, with all relevant documents associated with its procurement is essential.
Company that Manufactures/ Markets:
Assistance Cell in India:
For ONCOLOGY DRUG: ZYKADIA (Ceritinib) Capsules 150MG price.